Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2803679 | Growth Hormone & IGF Research | 2007 | 7 Pages |
Abstract
Our data shows that a subpopulation of FM patients with low serum IGF-I levels will fail the GHRH-arginine test. We, thus, recommend that the GH reserve of these patients should be evaluated further, as GH replacement may potentially improve the symptomatology of those with true GH deficiency. Additionally, the increased GH response rates to GHRH-arginine stimulation in the majority of FM patients with low serum IGF-I levels further supports the hypothesis of a dysregulated GH/IGF-I axis in the pathophysiology of FM.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Kevin C.J. Yuen, Robert M. Bennett, Cheryl A. Hryciw, Marie B. Cook, Sharon A. Rhoads, David M. Cook,